Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples. (Q34564863)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Catriona A. McLean

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Craig Hutton

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Andrew D Watt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Keyla A Perez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Alan Rembach

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Nicki A Sherrat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Lin Wai Hung

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Woan Mei Kok

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Michelle Fodero-Tavoletti

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Victor L Villemagne

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Kevin J Barnham

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Colin L Masters

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

25 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

published in

Acta Neuropathologica

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

549-564

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Alzheimer's disease-linked mutations in presenilin-1 result in a drastic loss of activity in purified γ-secretase complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Correlations of synaptic and pathological markers with cognition of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Abeta-globulomers are formed independently of the fibril pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Current status of vaccination therapies in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

A harmonized classification system for FTLD-TDP pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic beta-amyloid pathology known as 'cotton wool' plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

The Caenorhabditis elegans A beta 1-42 model of Alzheimer disease predominantly expresses A beta 3-42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Amino-terminal Deletions Enhance Aggregation of β-Amyloid Peptides in Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Imaging beta-amyloid burden in aging and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Resolving controversies on the path to Alzheimer's therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Synthesis of the side chain cross-linked tyrosine oligomers dityrosine, trityrosine, and pulcherosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Copper-mediated amyloid-beta toxicity is associated with an intermolecular histidine bridge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Stabilization of neurotoxic soluble beta-sheet-rich conformations of the Alzheimer's disease amyloid-beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Improved preparation of amyloid-beta peptides using DBU as Nalpha-Fmoc deprotection reagent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

A beta oligomers - a decade of discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: a clinicopathological study of four autopsy cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

Solid-phase synthesis of homodimeric peptides: preparation of covalently-linked dimers of amyloid β peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1083-Z

10.1007/S00401-013-1083-Z

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354835%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference